Cargando…

A new phenotypic classification system for dyslipidemias based on the standard lipid panel

BACKGROUND: Dyslipoproteinemias can be classified by their distinct lipoprotein patterns, which helps determine atherosclerotic cardiovascular disease (ASCVD) risk and directs lipid management but this has required advanced laboratory testing. OBJECTIVE: To develop a new algorithm for classifying li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sampson, Maureen, Ballout, Rami A., Soffer, Daniel, Wolska, Anna, Wilson, Sierra, Meeusen, Jeff, Donato, Leslie J., Fatica, Erica, Otvos, James D., Brinton, Eliot A., Rosenson, Robert S., Wilson, Peter, Amar, Marcelo, Shamburek, Robert, Karathanasis, Sotirios K., Remaley, Alan T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627634/ https://www.ncbi.nlm.nih.gov/pubmed/34838008 http://dx.doi.org/10.1186/s12944-021-01585-8

Ejemplares similares

Erratum to: Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids
por: Amar, Marcelo J. A., et al.
Publicado: (2017)

Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations
por: Sampson, Maureen, et al.
Publicado: (2022)

Identification of Dysbetalipoproteinemia by an Enhanced Sampson-NIH Equation for Very Low-Density Lipoprotein-Cholesterol
por: Sampson, Maureen, et al.
Publicado: (2022)

A Simple Fluorescent Cholesterol Labeling Method to Cryoprotect and Detect Plasma Lipoprotein-X
por: Neufeld, Edward B., et al.
Publicado: (2022)

The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19
por: Ballout, Rami A., et al.
Publicado: (2021)

Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids
por: Amar, Marcelo J. A., et al.
Publicado: (2016)

COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches
por: Sorokin, Alexander V., et al.
Publicado: (2020)

FRI099 Advanced Lipoprotein Analysis In Patients With Cushing’s Syndrome
por: Varghese, Ron T, et al.
Publicado: (2023)

Maintaining Cardiovascular Health in Patients With Mixed Dyslipidemia Optimizing the Management of Hypertriglyceridemia and Non-HDL Cholesterol
por: Ito, Matthew, et al.
Publicado: (2009)

Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia
por: Sosnowska, Bożena, et al.
Publicado: (2022)

LCAT protects against Lipoprotein‐X formation in a murine model of drug‐induced intrahepatic cholestasis
por: Amar, Marcelo J. A., et al.
Publicado: (2019)

Effects of Rosuvastatin and Atorvastatin on LDL and HDL Particle Concentrations in Patients With Metabolic Syndrome: A randomized, double-blind, controlled study
por: Rosenson, Robert S., et al.
Publicado: (2009)

The lysosome: A potential juncture between SARS‐CoV‐2 infectivity and Niemann‐Pick disease type C, with therapeutic implications
por: Ballout, Rami A., et al.
Publicado: (2020)

SAT-578 A Rare Case of Laboratory Hypertriglyceridemia: Glycerol Kinase Deficiency
por: Ueda, Masako, et al.
Publicado: (2020)

The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B
por: Garcia, Erwin, et al.
Publicado: (2020)

MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins
por: Vickers, Kasey C., et al.
Publicado: (2011)

Targeting Lipid Rafts—A Potential Therapy for COVID-19
por: Sviridov, Dmitri, et al.
Publicado: (2020)

Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
por: Wolska, Anna, et al.
Publicado: (2021)

Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity
por: Mietus-Snyder, Michele, et al.
Publicado: (2022)

Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON
por: Lorenzatti, Alberto J., et al.
Publicado: (2021)

LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias
por: Johansen, Christopher T., et al.
Publicado: (2014)

Lipoprotein-X and Lipoprotein-Z Induced Hyperviscosity Syndrome in the Setting of Cholestatic Liver Failure
por: Waksman, Ori, et al.
Publicado: (2022)

Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in Women
por: Mora, Samia, et al.
Publicado: (2010)

Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?
por: Cole, Justine, et al.
Publicado: (2023)

Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7
por: Quispe, Renato, et al.
Publicado: (2019)

Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias
por: Dron, Jacqueline S., et al.
Publicado: (2020)

Novel therapeutic targets and agents for pediatric dyslipidemia
por: Sunil, Bhuvana, et al.
Publicado: (2021)

Editorial: Rare dyslipidemias
por: Sadiq, Fouzia, et al.
Publicado: (2023)

Optimizing Dyslipidemia Outcomes
por: Lipsy, Robert J., et al.
Publicado: (2003)

A Modern Approach to Dyslipidemia
por: Berberich, Amanda J, et al.
Publicado: (2021)

Cardiometabolic risk factors and health behaviors in family caregivers
por: Ross, Alyson, et al.
Publicado: (2017)

Study Design, Rationale, and Baseline Characteristics: Evaluation of Fenofibric Acid on Carotid Intima-Media Thickness in Patients with Type IIb Dyslipidemia with Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial
por: Davidson, Michael, et al.
Publicado: (2012)

Overview of Pharmacologic Therapy for the Treatment of Dyslipidemia
por: Lipsy, Robert J.
Publicado: (2003)

Awareness, treatment, control, and determinants of dyslipidemia among adults in China
por: Opoku, Sampson, et al.
Publicado: (2021)

Understanding Attrition and Bolstering Retention in a Longitudinal Panel of Older Adults: ORANJ BOWL
por: Heid, Allison R, et al.
Publicado: (2021)

Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism
por: Liu, Huixing, et al.
Publicado: (2022)

Painful and Prolonged Muscle Cramps following Insulin Injections in a Patient with Type 2 Diabetes Mellitus: Revisiting the 1992 Duke Case
por: Ballout, Rami A., et al.
Publicado: (2017)

The Use of Genetic Testing Panels for Dyslipidemia: A Quality Improvement Project at the McGill University Health Centre
por: Pasqua, Melissa-Rosina, et al.
Publicado: (2021)

Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes
por: Gourgari, Evgenia A., et al.
Publicado: (2017)

Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice
por: Komatsu, Tomohiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k5q5s2ih5lgv4ids5inapf836f